MiR-29a activates hes1 by targeting Nfia in esophageal carcinoma cell line TE-1

Oncology Letters

Volumn 9, Issue 1, 2015, Pages 96-102

  Liu, Chang ^a   Duan, Ping ^b   Li, Bo ^b   Huang, Chuntian ^b,c   Jing, Ying ^b   Yan, Wenhai ^a,b  

^a Luohe Medical College   (China)

^b ZHENGZHOU UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Cell growth; Esophageal squamous cell carcinoma; MicroRNA; Notch; Nuclear factor 1 A

Indexed keywords

EPIDERMAL GROWTH FACTOR; LENTIVIRUS VECTOR; MICRORNA 29; MICRORNA 29A; NOTCH RECEPTOR; NUCLEAR FACTOR I; NUCLEAR FACTOR I A; TRANSCRIPTION FACTOR HES 1; UNCLASSIFIED DRUG;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; ESOPHAGUS CARCINOMA; FLOW CYTOMETRY; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; MTT ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

EID: 84911427872     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2678     Document Type: Article

References (32)

1. Ambros V: The functions of animal microRNAs. Nature 431: 350-355, 2004.
2. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
3. Dykxhoorn DM: MicroRNAs and metastasis: little RNAs go a long way. Cancer Res 70: 6401-6406, 2010.
4. Rebane A and Akdis CA: MicroRNAs: Essential players in the regulation of inflammation. J Allergy Clin Immunol 132: 15-26, 2013.
5. Szabo G and Bala S: MicroRNAs in liver disease. Nat Rev Gastroenterol Hepatol 10: 542-552, 2013.
6. Wu BL, Xu LY, Du ZP, et al: MiRNA profile in esophageal squamous cell carcinoma: downregulation of miR-143 and miR-145. World J Gastroenterol 17: 79-88, 2011.
7. South AP, Cho RJ and Aster JC: The double-edged sword of Notch signaling in cancer. Semin Cell Dev Biol 23: 458-464, 2012.
8. Ohashi S, Natsuizaka M, Yashiro-Ohtani Y, et al: NOTCH1 and NOTCH3 coordinate esophageal squamous differentiation through a CSL-dependent transcriptional network. Gastroenterology 139: 2113-2123, 2010.
9. Stange DE and Clevers H: Concise review: the yin and yang of intestinal (cancer) stem cells and their progenitors. Stem Cells 31: 2287-2295, 2013.
10. Louvi A and Artavanis-Tsakonas S: Notch signalling in vertebrate neural development. Nat Rev Neurosci 7: 93-102, 2006.
11. Yu C, Chen K, Zheng H, et al: Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis. Carcinogenesis 30: 894-901, 2009.
12. Le XF, McWatters A, Wiener J, Wu JY, Mills GB and Bast RC Jr: Anti-HER2 antibody and heregulin suppress growth of HER2-overexpressing human breast cancer cells through different mechanisms. Clin Cancer Res 6: 260-270, 2000.
13. Le XF, Almeida MI, Mao W, et al: Modulation of MicroRNA-194 and cell migration by HER2-targeting trastuzumab in breast cancer. PLoS One 7: e41170, 2012.
14. Gargalionis AN and Basdra EK: Insights in microRNAs biology. Curr Top Med Chem 13: 1493-1502, 2013.
15. Suzuki H, Maruyama R, Yamamoto E and Kai M: DNA methylation and microRNA dysregulation in cancer. Mol Oncol 6: 567-578, 2012.
16. Schmitt MJ, Margue C, Behrmann I and Kreis S: MiRNA-29: a microRNA family with tumor-suppressing and immune-modulating properties. Curr Mol Med 13: 572-585, 2013.
17. Kriegel AJ, Liu Y, Fang Y, Ding X and Liang M: The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury. Physiol Genomics 44: 237-244, 2012.
18. Garzon R, Garofalo M, Martelli MP, et al: Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci USA 105: 3945-3950, 2008.
19. Garzon R, Heaphy CE, Havelange V, et al: MicroRNA 29b functions in acute myeloid leukemia. Blood 114: 5331-5341, 2009.
20. Nguyen T, Kuo C, Nicholl MB, et al: Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma. Epigenetics 6: 388-394, 2011.
21. Xiong Y, Fang JH, Yun JP, et al: Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology 51: 836-845, 2010.
22. Cummins JM, He Y, Leary RJ, et al: The colorectal microRNAome. Proc Natl Acad Sci U S A 103: 3687-3692, 2006.
23. Li Y, Wang F, Xu J, et al: Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29. J Pathol 224: 484-495, 2011.
24. Yanaihara N, Caplen N, Bowman E, et al: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198, 2006.
25. Wu Z, Huang X, Huang X, Zou Q and Guo Y: The inhibitory role of Mir-29 in growth of breast cancer cells. J Exp Clin Cancer Res 32: 98, 2013.
26. Zhu XC, Dong QZ, Zhang XF, et al: MicroRNA-29a suppresses cell proliferation by targeting SPARC in hepatocellular carcinoma. Int J Mol Med 30: 1321-1326, 2012.
27. Calin GA, Ferracin M, Cimmino A, et al: A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353: 1793-1801, 2005.
28. Pekarsky Y, Santanam U, Cimmino A, et al: Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res 66: 11590-11593, 2006.
29. Sengupta S, Den Boon JA, Chen IH, et al: MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc Nat Acad Sci USA 105: 5874-5878, 2008.
30. Li Y, Kong D, Ahmad A, Bao B, Dyson G and Sarkar FH: Epigenetic deregulation of miR-29a and miR-1256 by isoflavone contributes to the inhibition of prostate cancer cell growth and invasion. Epigenetics 7: 940-949, 2012.
31. Ohashi S, Natsuizaka M, Naganuma S, et al: A NOTCH3-mediated squamous cell differentiation program limits expansion of EMT-competent cells that express the ZEB transcription factors. Cancer Res 71: 6836-6847, 2011.
32. Piper M, Barry G, Hawkins J, et al: NFIA controls telencephalic progenitor cell differentiation through repression of the Notch effector Hes1. J Neurosci 30: 9127-9139, 2010.